Literature DB >> 24512412

Surgical removal of an atrial septal occluder device embolized to the main pulmonary artery.

Emre Boysan1, Omer Faruk Cicek, Mustafa Cuneyt Cicek, Ziyaddin Hamurcu, Sami Gurkahraman.   

Abstract

Percutaneous closure of atrial septal defects in adults has emerged as an alternative to surgery. We report a sequela of such closure in a 16-year-old boy: embolization of the atrial septal defect occluder into the main pulmonary artery when the patient experienced an episode of intense coughing immediately after device deployment. We removed the device surgically and closed the atrial septal defect in a standard manner, with an autologous pericardial patch.

Entities:  

Mesh：

Year:  2014        PMID： 24512412      PMCID： PMC3967478          DOI： 10.14503/THIJ-12-3003

Source DB:  PubMed          Journal:  Tex Heart Inst J        ISSN： 0730-2347


  11 in total

1.  Presentation of an embolised Amplatzer septal occluder to the main pulmonary artery 2 years after implantation.

Authors:  Dimitrios N Lysitsas; Ben Wrigley; Pritwith Banerjee; Peter E Glennon; Jitendra M Parmar; Man Fai Shiu; Martin Been
Journal:  Int J Cardiol       Date:  2007-10-18       Impact factor: 4.164

2.  Secundum atrial septal defect. Nonoperative closure during cardiac catheterization.

Authors:  T D King; S L Thompson; C Steiner; N L Mills
Journal:  JAMA       Date:  1976-06-07       Impact factor: 56.272

3.  Surgical rescue of embolized amplatzer devices.

Authors:  Muneer M Amanullah; Maria T Siddiqui; Mubashir Z Khan; Mehnaz A Atiq
Journal:  J Card Surg       Date:  2011-04-11       Impact factor: 1.620

4.  Percutaneous closure with Amplatzer device is a safe and efficient alternative to surgery in adults with large atrial septal defects.

Authors:  J Losay; J Petit; V Lambert; G Esna; X Berthaux; P Brenot; C Angel
Journal:  Am Heart J       Date:  2001-09       Impact factor: 4.749

5.  Two cases of late embolization of Amplatzer septal occluder devices to the pulmonary artery following closure of secundum atrial septal defects.

Authors:  Walter E Mashman; Spencer B King; W Carl Jacobs; William L Ballard
Journal:  Catheter Cardiovasc Interv       Date:  2005-08       Impact factor: 2.692

6.  Erosion of Amplatzer septal occluder device after closure of secundum atrial septal defects: review of registry of complications and recommendations to minimize future risk.

Authors:  Zahid Amin; Ziyad M Hijazi; John L Bass; John P Cheatham; William E Hellenbrand; Charles S Kleinman
Journal:  Catheter Cardiovasc Interv       Date:  2004-12       Impact factor: 2.692

7.  Percutaneous rescue of left ventricular embolized amplatzer septal occluder device.

Authors:  Manrico Balbi; Giacomo Pongiglione; Gian Paolo Bezante
Journal:  Catheter Cardiovasc Interv       Date:  2008-10-01       Impact factor: 2.692

8.  Retrieval of an embolized amplatzer septal occluder.

Authors:  Kam Tim Chan; Boron Cheung Wah Cheng
Journal:  Catheter Cardiovasc Interv       Date:  2010-02-15       Impact factor: 2.692

9.  Surgical patch closure of atrial septal defects.

Authors:  Richard A Hopkins; Arthur A Bert; Bryan Buchholz; Kathleen Guarino; Merry Meyers
Journal:  Ann Thorac Surg       Date:  2004-06       Impact factor: 4.330

10.  The 'aortic rim' recount: embolization of interatrial septal occluder into the main pulmonary artery bifurcation after atrial septal defect closure.

Authors:  Manoranjan Misra; Adil Sadiq; Narayanan Namboodiri; Jayakumar Karunakaran
Journal:  Interact Cardiovasc Thorac Surg       Date:  2007-03-15
View more
  2 in total

1.  A Rare Ultra-Long-Term Complication of Occluder Recanalization Due to Spontaneous Perforation of Polyvinyl Alcohol Membrane of Atrial Septal Defect Occluder: A Case Report and Review of the Literature.

Authors:  Kun Xiang; Huanwei Zhuang; Qin Wu; Mi Tang; Jinfu Yang; Chengming Fan
Journal:  Front Cardiovasc Med       Date:  2022-07-22

2.  Midterm follow-up of transthoracic device closure of an atrial septal defect using the very large domestic occluder (44-48 mm), a single Chinese cardiac center experience.

Authors:  Qiang Chen; Hua Cao; Gui-Can Zhang; Liang-Wan Chen; Fan Xu; Jia-Xin Zhang
Journal:  J Cardiothorac Surg       Date:  2017-09-02       Impact factor: 1.637
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.